SCHEMBL3458022

SCHEMBL3458022

O=C(O)[C@H]1C[C@H](O)CN(C(=O)O)[C@@H]1C(=O)N1CC=C(c2ccccc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
GAA P10253 2/20 0.58
ADAM10 O14672 8/20 0.47
ERBB2 P04626 8/20 0.47
MMP2 P08253 6/20 0.47
MMP9 P14780 3/20 0.47
MMP3 P08254 2/20 0.47
MMP12 P39900 1/20 0.47
MMP14 P50281 1/20 0.47
ADAM8 P78325 1/20 0.47
ADAM17 P78536 1/20 0.47
ADAM33 Q9BZ11 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.44
ALOX15 P16050 2/20 0.44
TSHR P16473 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3458021 1.00 ALDH1A1 (0.58) ALDH1A1GAAADAM10ERBB2MMP2
SCHEMBL3457383 1.00 ALDH1A1 (0.58) ALDH1A1GAAADAM10ERBB2MMP2
SCHEMBL3458400 0.87 ALDH1A1 (0.58) ALDH1A1GAAADAM10ERBB2MMP2
SCHEMBL3456865 0.82 ADAM10 (0.48) ALDH1A1GAAADAM10ERBB2MMP2
SCHEMBL3458463 0.82 ALDH1A1 (0.50) ALDH1A1GAAADAM10ERBB2MMP2
SCHEMBL6023765 0.78 ADAM10 (0.50) ALDH1A1GAAADAM10ERBB2MMP2
SCHEMBL3457901 0.77 SIGMAR1 (0.51) ALDH1A1ADAM10ERBB2MMP2MMP9
SCHEMBL3457143 0.77 SIGMAR1 (0.51) ALDH1A1ADAM10ERBB2MMP2MMP9
SCHEMBL2172303 0.77 ADAM10 (0.55) ALDH1A1GAAADAM10ERBB2MMP2
SCHEMBL3457688 0.75 ADAM10 (0.69) ADAM10ERBB2MMP2MMP9MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2264030-A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases Incyte Corporation (US) 2010-12-22 EP disclosed